Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-30 @ 10:22 PM
Study NCT ID:
NCT04624633
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-27
First Post:
2020-11-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
Sponsor:
Jennifer R. Brown, MD, PhD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2028-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-05
First Submit QC Date:
None
Study First Post Date:
2020-11-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-31
Results First Submit QC Date:
None
Results First Post Date:
2025-02-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-06
Last Update Post Date:
2025-02-27
Last Update Post Date Type:
ACTUAL